Onconova Therapeutics, Inc. (ONTX)
Q2 2019 Earnings Conference Call
August 14, 2019 9:00 a.m. ET
Company Participants
Avi Oler - VP, Corporate Development, General Counsel
Steve Fruchtman - President and CEO
Mark Guerin - CFO
Ric Woodman - Chief Medical Officer
Conference Call Participants
Joe Pantginis - HC Wainwright
Naureen Quibria - Maxim Group
Ahu Demir - Noble Capital Markets
Yale Jen - Laidlaw & Company
Presentation
Operator
Good morning and welcome to Onconova Therapeutics' Corporate Update and Second Quarter 2019 Financial Results Conference Call.
At this time, I would like to turn the call